---
title: 'CACIC - Agente para Linux'
date: 2005-07-28T13:24:00.000-07:00
draft: false
url: /2005/07/cacic-agente-para-linux.html
tags: 
- Tech Tip
- Pessoal
---

#### _Original comment from:_
[Yves Junqueira](https://www.blogger.com/profile/00104361785049371212 "noreply@blogger.com") - <time datetime="2005-08-17T16:18:00.000-07:00">Aug 4, 2005</time>

_Original comment from: [djli30izxz](http://www.blogger.com/profile/11483583)_  
  
St0ck For Your Review - FCPG  
  
Current Profile  
Faceprint Global Solutions (FCPG)  
Current Price $0.15  
  
  
A U.S. based-company dedicated to the goal of  
bringing effective security solutions to the marketplace.  
  
With violent and white-collar terrorism on the rise,  
companies are starving for innovative security solutions.  
  
FCPG is set to bring hot new security solutions to  
the industry, with currently over 40 governmental and  
non-governmental contracts, being negotiated.  
  
Please Review Exactly What this Company Does.  
  
Why consider Faceprint Global Solutions (FCPG)?  
  
Faceprint Global Solutions (FCPG) holds the exclusive  
marketing rights from Keyvelop, to sell the world�s  
leading encryption technology to be distributed directly  
to the Healthcare industry in North America.  
  
Faceprint Global Solutions has completed its biometric  
software that recognizes facial features of individuals  
entering and leaving through airports, ship yards, banks,  
large buildings, etc.  
  
FCPG acquired Montreal-based Apometrix Technologies,  
which enhances the companies mission of being a  
full-service provider to the multi-application smart  
card industry. The North American market appears ready  
for significant expansion of price-competitive, proven,  
multi-application solutions on smart cards. Apometrix's  
forecast of over 300 customers and sales of more than $50  
million in North America over the next five years, appears  
very realistic, according to company management.  
  
Faceprint Global Solutions is currently in contract negotiations  
with over 40 governmental agencies and businesses seeking to use  
their encryption, biometric, and smart-card technologies.  
  
Breaking News for Faceprint Global Solutions (FCPG)  
  
Faceprint Global Solutions (FCPG) is pleased to announce that  
IBM will now offer the world�s leading encryption software to  
its major Healthcare clients in North America.  
  
With FCPG owning the exclusive North American rights to distribute  
the worlds leading encryption and transmission software developed by  
Keyvelop, FCPG is poised to capture large volumes of sales generated  
by customers currently using IBM�s software in the healthcare and other industries.  
�This is a very positive move for FCPG and for Keyvelop,� said FCPG  
CEO Pierre Cote. �We are very happy about the decision to go with IBM.  
This is a continuation of the progress made by everyone associated  
with FCPG and its partners.�  
  
Buell Duncan, IBM's general manager of ISV & Developer Relations commented,  
�Collaborating with Keyvelop will ensure that we develop open solutions  
that are easy to maintain and cost effective for our customers in the  
healthcare and life sciences industry.�  
  
Among other things, this new software technology which is currently  
being used by a number of European healthcare companies, is used to  
send any file, regardless of format or size. Encryption keys, evidence  
of transmission integrity with fingerprint calculation, time-stamping  
of all actions and status record updating, pre-checking sender and  
receiver identities, validating file opening dates are part of Keyvelop features.  
About FacePrint Global Solutions, Inc.  
  
FCPG operates a business, which develops and delivers a variety of  
technology solutions, including biometric software applications on  
smart cards and other support mediums (apometric solutions). FCPG�s  
products provide biometric solutions for identity authentication and a  
host of smart card- and biometrics-related hardware peripherals and  
software applications. Apometrix, FCPG�s wholly-owned subsidiary, combines  
on-card or in-chip multi-application management solutions with best-of-breed  
�in-card matching� biometrics. Keyvelop�s secure digital envelope solution  
and Apometrix�s on-card biometrics work together to produce the winning  
combination in the fields of security, traceability and identity management.  
Conclusion:  
  
The examples above show the Awesome, Earning Potential of little known  
Companies That Explode onto Investor�s Radar Screens. This sto,ck will  
not be a Secret for long. Then You May Feel the Desire to Act Right Now!  
And Please Watch This One Trade!  
  
GO FCPG!  
  
Disclaimer:  
Information within this email contains "forwardlooking statements" within  
the meaning of Section 27Aof the Securities Act of 1933 and Section 21B of  
the Securities Exchange Act of 1934. Any statements that express or involve  
discussions with respect to predictions, expectations, beliefs,  
plans, projections, objectives, goals, assumptions or future events or  
performance are not statements of historical fact and may be "forward  
looking statements". "Forward |ooking statements" are based on  
expectations, estimates and projections at the time the statements are made  
that involve a number of risks and uncertainties which could cause actual  
results or events to differ materially from those presently anticipated.  
We were paid a sum of three thousand USD to disseminate this information from  
ir marketing. Forward loking statements in this action may be identified through  
the use of words such as "projects", "foresee", "expects", "will", "anticipates",  
"estimates", "believes", "understands" or that by statements indicating  
certain actions "may", "could", or "might" occur. Risk factors include  
general economic and business conditions, the ability to acquire and develop  
specific projects, the ability to fund operations and changes in consumer  
and business consumption habits and other factors overwhich the company has  
little or no control. The publisher of this newsletter does not represent  
that the information contained herein are true and correct.
<hr />
